Category Archives: Press Releases
2012.3.5 Patient Advocates Encouraged That Ovarian Cancer Trial Will Advance, Thanks to FDA Approval to Re-Import Doxil®
Washington, DC—Endocyte, Inc. announced today that is has received approval from the Food and Drug Administration (FDA) to re-import supplies of Doxil® from Europe for use in the company’s PROCEED … Continue reading
Also posted in Blog
Leave a comment
2011.12.20 Victory for Women with Ovarian Cancer: Congress Agrees to Fund Needed Research, Education Programs for Fiscal Year 2012
Washington, DC—The omnibus appropriations bill passed by Congress on December 17 includes funding for three ovarian cancer research and education programs. The Ovarian Cancer National Alliance worked with thousands of … Continue reading
Also posted in News
Leave a comment
2011.11.21 Ovarian Cancer Advocates Support Broad Access to Oral Contraceptives as Preventive Medicine; Oppose Broadening of Religious Exemptions
Washington, DC—In July 2011, the Department of Health and Human Services adopted recommendations on services that would be covered with no co-pay for women under the Affordable Care Act, including … Continue reading
Also posted in News
Leave a comment
2011.11.18 Ovarian Cancer Advocates Troubled by FDA Decision on Avastin and Breast Cancer
Washington, DC—Today the Food and Drug Administration (FDA) announced that it would remove metastatic breast cancer from the label for Avastin (bevacizumab). This decision follows recommendations made in June by … Continue reading
Also posted in News
Leave a comment
2011.10.06 New App Helps Women Track Signs of Ovarian Cancer, Know When to Visit a Doctor
Washington, DC—A free app released today by the Ovarian Cancer National Alliance will help a woman learn more about the risks, signs and symptoms of ovarian cancer, and determine whether … Continue reading
Avon Books and the Ovarian Cancer National Alliance Urge Women to K.I.S.S. and Teal
September is National Ovarian Cancer Awareness Month, and Avon Books is joining forces with the Ovarian Cancer National Alliance to urge women to learn about the symptoms of ovarian cancer–and … Continue reading
Also posted in Blog
Leave a comment
2011.07.19 Ovarian Cancer Advocates Praise Recommendation to Cover Birth Control as Preventive Medicine
Washington, DC—Today the Institute of Medicine recommended that birth control be classified as a preventive service for women. If the Department of Health and Human Services adopts these recommendations, health … Continue reading
Also posted in News
Leave a comment
2011.06.29 Advocates Concerned that FDA Decision on Avastin and Breast Cancer Will Harm Women with Ovarian Cancer
Washington, DC— Today, a panel of experts convened by the Food and Drug Administration (FDA) unanimously recommended that the label for Avastin (bevacizumab) no longer include metastatic breast cancer. The … Continue reading
Also posted in News
Leave a comment
2011.6.28 Ovarian Cancer National Alliance Urges FDA Not to Limit Access to Avastin (Bevacizumab) for Women with Ovarian Cancer
FOR IMMEDIATE RELEASE June 28, 2011 Ovarian Cancer National Alliance Urges FDA Not to Limit Access to Avastin (Bevacizumab) for Women with Ovarian Cancer Washington, DC—On Tuesday, June 28, Dr. … Continue reading
2011.4.13 Statement about Decrease in Ovarian Cancer Deaths
FOR IMMEDIATE RELEASE April 19, 2011 Advocates Say Decline in Ovarian Cancer Deaths is “Right Direction, but Far Too Slow” Washington, DC—In April, the Journal of the National Cancer Institute … Continue reading
2011.6.22 Ovarian Cancer Survivor Testifies in Support of DoD Research Program
FOR IMMEDIATE RELEASE June 22, 2011 Ovarian Cancer Survivor Testifies in Support of DoD Research Program Washington, DC—Ovarian cancer survivor Susan Leighton testified today before the Senate Appropriations Subcommittee on … Continue reading
2011.7.9 Ovarian Cancer National Alliance Annual Conference
MEDIA ADVISORY WHAT The Ovarian Cancer National Alliance Annual Conference brings hundreds of women with ovarian cancer, researchers and caregivers to Washington, DC. This year’s conference features presentations on groundbreaking … Continue reading












